These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 18344973)
1. Lentivector-mediated rescue from cerebellar ataxia in a mouse model of spinocerebellar ataxia. Torashima T; Koyama C; Iizuka A; Mitsumura K; Takayama K; Yanagi S; Oue M; Yamaguchi H; Hirai H EMBO Rep; 2008 Apr; 9(4):393-9. PubMed ID: 18344973 [TBL] [Abstract][Full Text] [Related]
2. CRMP5-associated GTPase (CRAG) protein protects neuronal cells against cytotoxicity of expanded polyglutamine protein partially via c-Fos-dependent activator protein-1 activation. Nagashima S; Fukuda T; Kubota Y; Sugiura A; Nakao M; Inatome R; Yanagi S J Biol Chem; 2011 Sep; 286(39):33879-89. PubMed ID: 21832068 [TBL] [Abstract][Full Text] [Related]
3. AAV-Mediated CAG-Targeting Selectively Reduces Polyglutamine-Expanded Protein and Attenuates Disease Phenotypes in a Spinocerebellar Ataxia Mouse Model. Niewiadomska-Cimicka A; Fievet L; Surdyka M; Jesion E; Keime C; Singer E; Eisenmann A; Kalinowska-Poska Z; Nguyen HHP; Fiszer A; Figiel M; Trottier Y Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673939 [TBL] [Abstract][Full Text] [Related]
4. A novel GTPase, CRAG, mediates promyelocytic leukemia protein-associated nuclear body formation and degradation of expanded polyglutamine protein. Qin Q; Inatome R; Hotta A; Kojima M; Yamamura H; Hirai H; Yoshizawa T; Tanaka H; Fukami K; Yanagi S J Cell Biol; 2006 Feb; 172(4):497-504. PubMed ID: 16461359 [TBL] [Abstract][Full Text] [Related]
5. Transcriptional dysregulation of TrkA associates with neurodegeneration in spinocerebellar ataxia type 17. Shah AG; Friedman MJ; Huang S; Roberts M; Li XJ; Li S Hum Mol Genet; 2009 Nov; 18(21):4141-52. PubMed ID: 19643914 [TBL] [Abstract][Full Text] [Related]
6. Reduced brain-derived neurotrophic factor (BDNF) mRNA expression and presence of BDNF-immunoreactive granules in the spinocerebellar ataxia type 6 (SCA6) cerebellum. Takahashi M; Ishikawa K; Sato N; Obayashi M; Niimi Y; Ishiguro T; Yamada M; Toyoshima Y; Takahashi H; Kato T; Takao M; Murayama S; Mori O; Eishi Y; Mizusawa H Neuropathology; 2012 Dec; 32(6):595-603. PubMed ID: 22393909 [TBL] [Abstract][Full Text] [Related]
7. Delayed spinocerebellar ataxia in transgenic mice expressing mutant ubiquitin. Tsirigotis M; Tang MY; Beyers M; Zhang M; Woulfe J; Gray DA Neuropathol Appl Neurobiol; 2006 Feb; 32(1):26-39. PubMed ID: 16409551 [TBL] [Abstract][Full Text] [Related]
8. An miRNA-mediated therapy for SCA6 blocks IRES-driven translation of the CACNA1A second cistron. Miyazaki Y; Du X; Muramatsu S; Gomez CM Sci Transl Med; 2016 Jul; 8(347):347ra94. PubMed ID: 27412786 [TBL] [Abstract][Full Text] [Related]
9. Purkinje cell COX deficiency and mtDNA depletion in an animal model of spinocerebellar ataxia type 1. Ripolone M; Lucchini V; Ronchi D; Fagiolari G; Bordoni A; Fortunato F; Mondello S; Bonato S; Meregalli M; Torrente Y; Corti S; Comi GP; Moggio M; Sciacco M J Neurosci Res; 2018 Sep; 96(9):1576-1585. PubMed ID: 30113722 [TBL] [Abstract][Full Text] [Related]
10. Basic research on cerebellar gene therapy using lentiviral vectors. Hirai H Cerebellum; 2012 Jun; 11(2):443-5. PubMed ID: 22120847 [TBL] [Abstract][Full Text] [Related]
11. The carboxy-terminal fragment of alpha(1A) calcium channel preferentially aggregates in the cytoplasm of human spinocerebellar ataxia type 6 Purkinje cells. Ishiguro T; Ishikawa K; Takahashi M; Obayashi M; Amino T; Sato N; Sakamoto M; Fujigasaki H; Tsuruta F; Dolmetsch R; Arai T; Sasaki H; Nagashima K; Kato T; Yamada M; Takahashi H; Hashizume Y; Mizusawa H Acta Neuropathol; 2010 Apr; 119(4):447-64. PubMed ID: 20043227 [TBL] [Abstract][Full Text] [Related]
12. Spinocerebellar ataxia type 1--modeling the pathogenesis of a polyglutamine neurodegenerative disorder in transgenic mice. Clark HB; Orr HT J Neuropathol Exp Neurol; 2000 Apr; 59(4):265-70. PubMed ID: 10759181 [TBL] [Abstract][Full Text] [Related]
13. Cerebellum-enriched protein INPP5A contributes to selective neuropathology in mouse model of spinocerebellar ataxias type 17. Liu Q; Huang S; Yin P; Yang S; Zhang J; Jing L; Cheng S; Tang B; Li XJ; Pan Y; Li S Nat Commun; 2020 Feb; 11(1):1101. PubMed ID: 32107387 [TBL] [Abstract][Full Text] [Related]
14. Computational analysis of calcium signaling and membrane electrophysiology in cerebellar Purkinje neurons associated with ataxia. Brown SA; Loew LM BMC Syst Biol; 2012 Jun; 6():70. PubMed ID: 22703638 [TBL] [Abstract][Full Text] [Related]
15. Relationship between ataxin-1 nuclear inclusions and Purkinje cell specific proteins in SCA-1 transgenic mice. Vig PJ; Subramony SH; Qin Z; McDaniel DO; Fratkin JD J Neurol Sci; 2000 Mar; 174(2):100-10. PubMed ID: 10727695 [TBL] [Abstract][Full Text] [Related]
16. Post-symptomatic Delivery of Brain-Derived Neurotrophic Factor (BDNF) Ameliorates Spinocerebellar Ataxia Type 1 (SCA1) Pathogenesis. Sheeler C; Rosa JG; Borgenheimer E; Mellesmoen A; Rainwater O; Cvetanovic M Cerebellum; 2021 Jun; 20(3):420-429. PubMed ID: 33394333 [TBL] [Abstract][Full Text] [Related]
17. Broad distribution of ataxin 1 silencing in rhesus cerebella for spinocerebellar ataxia type 1 therapy. Keiser MS; Kordower JH; Gonzalez-Alegre P; Davidson BL Brain; 2015 Dec; 138(Pt 12):3555-66. PubMed ID: 26490326 [TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cell transplantation ameliorates motor function deterioration of spinocerebellar ataxia by rescuing cerebellar Purkinje cells. Chang YK; Chen MH; Chiang YH; Chen YF; Ma WH; Tseng CY; Soong BW; Ho JH; Lee OK J Biomed Sci; 2011 Aug; 18(1):54. PubMed ID: 21824437 [TBL] [Abstract][Full Text] [Related]
19. A New Mouse Model Related to SCA14 Carrying a Pseudosubstrate Domain Mutation in PKCĪ³ Shows Perturbed Purkinje Cell Maturation and Ataxic Motor Behavior. Shimobayashi E; Kapfhammer JP J Neurosci; 2021 Mar; 41(9):2053-2068. PubMed ID: 33478986 [TBL] [Abstract][Full Text] [Related]
20. One-year follow-up of transgene expression by integrase-defective lentiviral vectors and their therapeutic potential in spinocerebellar ataxia model mice. Saida H; Matsuzaki Y; Takayama K; Iizuka A; Konno A; Yanagi S; Hirai H Gene Ther; 2014 Sep; 21(9):820-7. PubMed ID: 24989813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]